Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Forlle'd is a Japanese luxury cosmeceutical company that develops advanced skincare products using proprietary low molecular weight technology. The company's core innovation involves reducing the size of hyaluronic acid molecules to 5 nanometers, allowing them to penetrate deep into the dermal layers without injection. Their formulations combine these ultra-low molecular weight substances with ionized essential minerals and platinum to promote skin rejuvenation and antioxidant protection. Forlle'd serves the professional aesthetic market, providing products to dermatologists, plastic surgeons, and high-end spas worldwide. The brand's scientific approach is based on Nobel Prize-winning research methods for molecular weight reduction.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Forlle'd.